The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
H H S Department of Health and Human Services
U.S. Department of Health and Human Services
Health Resources and Services Administration

A-Z Index  |  Questions?   |  HRSA Mobile

  • Print this
  • Email this

Sickle Cell Disease Treatment Demonstration Program Regional Collaborative Technical Assistance

Apply to HRSA-14-078 at by May 27

Application Help Webinar (No need to register for login/password. Just use guest entry.)

Frequently Asked Questions & Answers (updated 05/14/2014)

The purpose of this funding opportunity is to support the development and establishment of systemic mechanisms to improve the prevention and treatment of sickle cell disease and its complications, including

  • Coordination of service delivery for individuals with sickle cell disease
  • Genetic counseling and testing
  • Bundling of technical services related to the prevention and treatment of sickle cell disease
  • Training of health professionals
  • Expansion and coordination of education, treatment and continuity of care for individuals with sickle cell disease

The funds will support the development of four Sickle Cell Regional Collaboratives that will make sub-awards to state-level partners and work with them and other organizations to improve the delivery of care for people with sickle cell disease.

Each awardee will take the lead for establishing a collaborative within its region, will serve as sickle cell disease technical assistance center in the region and will collect and maintain sickle cell disease data for the region.

See also: HRSA Sickle Cell Disease Programs | HHS Region Map | Community Forum on Future Directions for Sickle Cell Disease Treatment Demonstration Program presentation slides (PDF - 1.8 MB)


Federally-qualified health centers, nonprofit hospitals or clinics, or university health centers that provide primary health care that

  1. Has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals with sickle cell disease; and 
  2. Demonstrates that it or the partner "pediatric and adult hematologists in the region and other regional experts in sickle cell disease at tertiary and academic health centers
    and State and county health offices" described in section 712(c)(2)(C) of the American Jobs Creation Act of 2004 (PDF - 1.6 MB) have at least five years’ experience working with individuals who have sickle cell disease. 

Faith-based and community-based organizations that meet these qualifications are eligible. 

Current Sickle Cell Disease Newborn Screening Program grantees that meet these qualifications are eligible.


HRSA expects to make four cooperative agreement awards (no more than one in any HHS region). Awards will be as much as $850,000 per year for the 3-year project period.

Register Today

Before you can apply for this funding opportunity, you must register in three places: DUNS, SAM, and

Be sure to provide complete and consistent information to all three systems. If there is a problem anywhere in the process, your registration can take 4 weeks or longer.

Before you do anything else, make sure you Register & Get Ready